Follow the Alivus Life Sciences Limited share price and the full insider trade history of the company, a listed issuer based in India. Shares trade on IN IN, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Alivus Life Sciences Limited has logged 8 public disclosures. Market capitalisation: €132.4bn. The latest transaction was disclosed on 15 July 2024 (Sale). Among the most active insiders: GLENN SALDANHA. All data is accessible without an account.
8
Insider Decl.
0
Thresholds
€162m
3 ops.
Buy Volume
€697m
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Alivus Life Sciences Limited Strong Buy (bullish), based on 4 analysts. Average price target: ₹1,228.75.
10Σ signal
Buys €162m€697m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 4,311 of 26,092 companies
69.0
score / 100
Value
55
Quality
83
FCF yld2.0%
Earn yld4.3%
EV/EBITDA·
ROE18%
Gross mgn58%
Net mgn22%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.